Skip to content
Riskpilot
← Back to search
Sign in
Get full access
EriPharma AB
AB
Active
Org 5592523962
Economic activity was not specified by tax authority
·
NACE 0000
Est. 2020 · 6 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Economic activity was not specified by tax authority
/
EriPharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−12
−10
−27
−42
−42
Depreciation & amort.
−0
−0
—
—
−0
EBIT
−12
−10
−27
−42
−42
Net financials
—
—
−17
−27
−27
Profit before tax
−12
−10
−44
32
32
Tax
−0
−0
—
—
−0
Net profit
−12
−10
−44
32
32
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
304
304
1 180
1 278
1 722
Equity
13
53
59
90
425
Long-term debt
0
0
710
1 038
1 018
Short-term debt
291
251
412
150
280
Total debt
291
251
1 121
1 188
1 298
Financial ratios
5-year trend
EBITDA margin
-4200000.0%
This company
15.8%
Market median
-26582378% vs market
2020
2024
Equity ratio
24.7%
This company
38.2%
Market median
-35% vs market
2020
2024
Return on equity
7.5%
This company
18.4%
Market median
-59% vs market
2020
2024
Net profit margin
3200000.0%
This company
8.1%
Market median
+39506073% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
3.05×
This company
0.62×
Market median
-392% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-04-01 – 2020-12-31
View
PDF
More on EriPharma AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
